Skip to main content
Figure 1 | BMC Complementary and Alternative Medicine

Figure 1

From: Oridonin alters the expression profiles of MicroRNAs in BxPC-3 human pancreatic cancer cells

Figure 1

Distribution of GO categories for the predicted target genes of differentially expressed miRNAs identified in BxPC-3 cells treated with oridonin. The left vertical axis represents the percent of genes, the right vertical axis represents the number of genes and the horizontal axis represents the GO category, including biological processes, cellular components and molecular functions.

Back to article page